Deadline: 16-Apr-26
The European Commission is offering funding under Horizon Europe to advance regulatory science for patient-centred health technologies. With a total budget of €19.6 million and grants between €4 million and €6 million, the programme supports improved evaluation methods and faster adoption of safe, effective innovations.
The focus is on evidence-based regulation, digital health technologies, and lifecycle assessment to enhance healthcare outcomes across the EU.
This programme supports research and innovation in regulatory science, aiming to improve how health technologies are evaluated, approved, and adopted.
It focuses on strengthening the evidence base and methodologies used by regulators to ensure that innovative healthcare solutions are:
- Safe
- Effective
- Efficiently integrated into healthcare systems
Key Programme Details
Funding Information
- Total Budget: €19,600,000
- Grant Size: €4,000,000 – €6,000,000
- Programme Type: Research and Innovation Actions
- Scope: International participation allowed
Programme Objectives
- Improve evidence-driven evaluation methodologies
- Support better regulatory and policy decision-making
- Accelerate uptake of safe and effective health technologies
- Promote personalised and patient-centred healthcare
Core Focus Areas
1. Regulatory Science Innovation
- Develop advanced methods for evaluating health technologies
- Improve regulatory frameworks and standards
2. Evidence Generation and Evaluation
- Identify new sources of clinical and real-world evidence
- Strengthen data quality and reliability for decision-making
3. Lifecycle Approach to Health Technologies
- Cover all stages:
- Development
- Assessment
- Approval
- Post-market surveillance
- Ensure continuous safety and performance monitoring
4. Digital and Biomedical Innovation
- Integrate:
- Artificial Intelligence (AI)
- Virtual human twins
- Predictive modelling tools
- Enhance clinical evaluation processes
5. Policy and Regulatory Impact
- Contribute to updated:
- Regulatory policies
- Guidelines
- Evaluation tools
What Type of Projects Are Funded?
The programme funds pre-competitive research and innovation, including:
- Tools and methods for regulatory evaluation
- Technologies supporting clinical assessment and monitoring
- Models for predicting biological and treatment outcomes
- Frameworks for integrating digital health innovations
Key Project Requirements
Projects must:
- Focus on regulatory science and evidence generation
- Address safety and performance across the lifecycle
- Demonstrate applicability to real-world regulatory systems
- Support policy and guideline development
- Include innovative and scalable solutions
Who Is Eligible?
Eligible Participants
- Any legal entity worldwide
- Universities and research institutions
- Private companies and SMEs
- NGOs and non-profit organisations
- International organisations
H3: Participation Requirements
- Must comply with Horizon Europe eligibility rules
- Applicants must:
- Register in the Participant Register
- Obtain a Participant Identification Code (PIC)
H3: Consortium Expectations
- Collaborative and cross-sectoral partnerships encouraged
- Multidisciplinary expertise in health, technology, and regulation
Why This Programme Matters
H3: Improving Healthcare Innovation Uptake
- Enables faster approval of new technologies
- Reduces delays in bringing innovations to market
H3: Strengthening Patient Safety
- Ensures rigorous evaluation of safety and effectiveness
- Improves trust in healthcare technologies
H3: Supporting Digital Transformation
- Integrates advanced tools like AI into regulatory processes
- Modernises healthcare evaluation systems
How to Apply (Step-by-Step Guide)
Step 1: Identify the Call
- Review relevant calls under Horizon Europe
- Ensure alignment with regulatory science objectives
Step 2: Register Your Organisation
- Sign up in the Participant Register
- Obtain a Participant Identification Code (PIC)
Step 3: Build a Consortium
- Include:
- Research institutions
- Industry partners
- Regulatory experts
- Ensure multidisciplinary collaboration
Step 4: Develop the Proposal
- Define:
- Regulatory challenge
- Innovation approach
- Expected policy and clinical impact
Step 5: Plan for Implementation
- Demonstrate real-world applicability
- Include scalability and integration into regulatory systems
Step 6: Submit Application
- Apply through the European Commission portal
- Follow submission guidelines and deadlines
Common Mistakes to Avoid
- Weak focus on regulatory relevance
- Lack of clear evidence-generation strategy
- Ignoring lifecycle approach to technologies
- Limited integration of digital innovations
- Poor alignment with policy impact
Tips for a Strong Application
- Focus on evidence-based regulatory innovation
- Include strong expertise in health technology assessment
- Demonstrate policy and real-world impact
- Use advanced digital and biomedical tools
- Ensure scalability and long-term relevance
Frequently Asked Questions (FAQ)
1. Who can apply for this funding?
Any legal entity worldwide, including universities, companies, NGOs, and international organisations.
2. What is the funding range?
Projects receive between €4 million and €6 million.
3. What is regulatory science?
It is the science of developing tools, standards, and approaches to evaluate the safety, effectiveness, and quality of health technologies.
4. Is a consortium required?
Collaboration is strongly encouraged, especially across sectors and disciplines.
5. What technologies are supported?
AI, digital health tools, predictive models, and biomedical innovations.
6. What is meant by lifecycle approach?
It refers to evaluating technologies from development through post-market monitoring.
7. What outcomes are expected?
Improved regulatory frameworks, faster adoption of innovations, and better patient outcomes.
Conclusion
The European Commission Regulatory Science Grants offer a strategic opportunity to modernise how healthcare innovations are evaluated and adopted.
By strengthening evidence-based methodologies and integrating advanced technologies, this programme supports safer, faster, and more effective healthcare innovation across Europe.
For more information, visit European Commission.
